Clinical trial
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
- Lead sponsor
- University Hospital, Limoges
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 9, 2024
- Completion date
- December 1, 2029
- Enrollment
- 756 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
chronic liver disease